• Rosa Girón, Rafael Golpe, and Miguel Ángel Martínez-García.
• Servicio de Neumología, Hospital Universitario La Princesa, Madrid, España.
• Med Clin (Barc). 2024 Jul 26; 163 (2): 819081-90.

AbstractBronchiectasis is a clinical-radiological condition composed of irreversible bronchial dilation due to inflammation and infection of the airways, which causes respiratory symptoms, usually productive cough and infectious exacerbations. Bronchiectasis can have multiple causes, both pulmonary and extrapulmonary, and its clinical presentation is very heterogenous. Its prevalence is unknown, although up to 35-50% of severe COPD and 25% of severe asthma present them, so their underdiagnosis is evident. Chronic bacterial bronchial infection is common, and Pseudomonas aeruginosa is the pathogen that has been found to imply a worse prognosis. Treatment of bronchiectasis has three fundamental characteristics: it must be multidisciplinary (involvement of several specialties), pyramidal (from primary care to the most specialized units) and multidimensional (management of all aspects that make up the disease).Copyright © 2024 Elsevier España, S.L.U. All rights reserved.

19 keywords...

hide…